Incident Report
Subform I: General Information
1. Report Type.
Update the report
Incident Report Number: 2008-1178
2. Registrant Information.
Registrant Reference Number: Prosar case 1-15829992
Registrant Name (Full Legal Name no abbreviations): Scotts Canada Ltd.
Address: 2000 Argentia Road Plaza 5 Suite 101
City: Mississauga
Prov / State: Ontario
Country: Canada
Postal Code: L5N2R7
3. Select the appropriate subform(s) for the incident.
Human
4. Date registrant was first informed of the incident.
26-FEB-08
5. Location of incident.
Country: CANADA
Prov / State: ONTARIO
6. Date incident was first observed.
24-FEB-08
Product Description
7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.
Active(s)
PMRA Registration No. 22027
PMRA Submission No.
EPA Registration No.
Product Name: ORTHO HOME DEFENSE MAX NO-PEST INSECTICIDE STRIP
- Active Ingredient(s)
- DICHLORVOS PLUS RELATED ACTIVE COMPOUNDS
7. b) Type of formulation.
Application Information
8. Product was applied?
Yes
9. Application Rate.
Unknown
10. Site pesticide was applied to (select all that apply).
Site: Unknown / Inconnu
11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).
The reporter placed several product strips in an unknown location on 2/22/08. The product contains between 19-21% Dichlorvos by weight. The reporter denied any direct contact between the product and the areas of her body affected by symptoms (face, neck). It is not known if the reporter used any protective equipment while using the product.
To be determined by Registrant
12. In your opinion, was the product used according to the label instructions?
Unknown
Subform II: Human Incident Report (A separate form for each person affected)
1. Source of Report.
Data Subject
2. Demographic information of data subject
Sex: Female
Age: >19 <=64 yrs / >19 <=64 ans
3. List all symptoms, using the selections below.
System
- Skin
- Symptom - Hives
- Symptom - Rash
- Specify - Blotches to face and neck
- Nervous and Muscular Systems
4. How long did the symptoms last?
>1 wk <=1 mo / > 1 sem < = 1 mois
5. Was medical treatment provided? Provide details in question 13.
Yes
6. a) Was the person hospitalized?
Unknown
6. b) For how long?
7. Exposure scenario
Non-occupational
8. How did exposure occur? (Select all that apply)
Application
9. If the exposure occured during application or re-entry, what protective clothing was worn? (select all that apply)
Unknown
10. Route(s) of exposure.
Unknown
11. What was the length of exposure?
Unknown / Inconnu
12. Time between exposure and onset of symptoms.
>24 hrs <=3 days / >24 h <=3 jours
13. Provide any additional details about the incident (eg. description of the frequency and severity of the symptoms, type of medical treatment, results from medical tests, outcome of the incident, amount of pesticide exposed to, etc.)
(#): The reporter called on 2/26/08 to report she was experiencing an allergic reaction to a product she had used on 2/24/08 which contains the active ingredient Dichlorvos. The reporter stated she has a history of allergies to multiple items, and complained of an allergic reaction (blotches to the face and neck) but denied any direct contact between the product and the affected areas. It is not known if the reporter used any protective equipment while using the product. Decontamination and treatment advice was given, which included washing the affected skin with soap and water and using Vitamin E, aloe or cortisone creams or lotions. The reporter was advised to seek a medical evaluation if her symptoms persisted or worsened. A follow-up call was placed 3/7/08 and the reporter responded on 3/10/08. At that time it was revealed that her symptoms were now improving after initially worsening. According to the reporter, she ended up with terrible hives and severe headaches. She did see her physician but it is not known what diagnosis and treatment was given.
To be determined by Registrant
14. Severity classification.
Moderate
15. Provide supplemental information here.